Masuda Miwa, Nakanishi Koichi, Yoshizawa Nobuyuki, Iijima Kazumoto, Yoshikawa Norishige
Faculty of Health Science, Kobe University School of Medicine, Kobe, Hyogo, Japan.
Am J Kidney Dis. 2003 Feb;41(2):366-70. doi: 10.1053/ajkd.2003.50045.
Although the pathogenesis of Henoch-Schönlein nephritis (HSN) remains unclear, there is substantial evidence that it is an immune complex-mediated disease. HSN is preceded by upper-respiratory tract infection in 30% to 50% of patients, but there is no evidence that group A streptococcal (GAS) infection has a pathogenetic role in this disease. Recently, nephritis-associated plasmin receptor (NAPlr), a GAS antigen, was found primarily in the glomerular mesangium of patients with early-stage acute poststreptococcal glomerulonephritis.
To determine the possible role of NAPlr in HSN, expression of the receptor was determined in glomeruli using fluorescein isothiocyanate-labeled rabbit polyclonal anti-NAPIr antibody, and serum antistreptolysin O (ASO) titers were measured in children with HSN.
Ten of 33 patients (30%) with HSN showed segmental or global mesangial staining with NAPlr antibody, whereas only 4 of 120 patients (3%) with other renal diseases were positive (P < 0.001, Fisher's exact test). Patients with HSN also showed significantly greater ASO titers than patients with other renal diseases (P = 0.03, Mann-Whitney U test). Serum ASO titers were significantly greater in patients with HSN with than without glomerular NAPlr antigen (P = 0.03, Mann-Whitney U test).
These findings suggest that the deposition of NAPlr in the mesangium, induced by GAS infection, may have a role in the pathogenesis of HSN in some patients. Am J Kidney Dis 41:366-370.
尽管紫癜性肾炎(HSN)的发病机制尚不清楚,但有大量证据表明它是一种免疫复合物介导的疾病。30%至50%的患者在紫癜性肾炎发病前有上呼吸道感染,但没有证据表明A组链球菌(GAS)感染在该疾病中具有致病作用。最近,在早期急性链球菌感染后肾小球肾炎患者的肾小球系膜中主要发现了一种GAS抗原——肾炎相关纤溶酶受体(NAPlr)。
为了确定NAPlr在紫癜性肾炎中的可能作用,使用异硫氰酸荧光素标记的兔多克隆抗NAPlr抗体在肾小球中检测该受体的表达,并检测紫癜性肾炎患儿的血清抗链球菌溶血素O(ASO)滴度。
33例紫癜性肾炎患者中有10例(30%)显示NAPlr抗体呈节段性或弥漫性系膜染色,而120例其他肾脏疾病患者中只有4例(3%)呈阳性(P<0.001,Fisher精确检验)。紫癜性肾炎患者的ASO滴度也显著高于其他肾脏疾病患者(P = 0.03,Mann-Whitney U检验)。有肾小球NAPlr抗原的紫癜性肾炎患者的血清ASO滴度显著高于无该抗原的患者(P = 0.03,Mann-Whitney U检验)。
这些发现表明,GAS感染诱导的NAPlr在系膜中的沉积可能在某些患者的紫癜性肾炎发病机制中起作用。《美国肾脏病杂志》41:366 - 370。